Pharma Mar, SA Financials

Market Capitalization €1.44 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	74.16
Forward PE	22.71
Price to Sales TTM	€8.22
Price to Book MRQ	€7.07
Enterprise to Revenue	7.44
Enterprise to EBITDA	111.57

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	11.31%
Operating Margin	-7.94%
Return on Assets TTM	1.44%
Return on Equity TTM	10.19%

Income Statement

Revenue TTM	€175,747,008
Revenue per Share TTM	€9.97
Quarterly Revenue Growth	2.30%
Gross Profit TTM	€165,928,000
EBITDA	€21,046,000
Net Income to Common TTM	€19,876,000
Diluted EPS TTM	€1.13
Quarterly Earnings Growth YoY	2.35%

Balance Sheet

Total Cash MRQ	€140,846,000
Total Cash per Share MRQ	€8.01
Total Debt MRQ	€
Total Debt to Equity MRQ	26.30
Current Ratio MRQ	2.97
Book Value per Share MRQ	€11.86

Cash Flow

Operating Cash Flow TTM	€-9,560,000
Levered Free Cash Flow TTM	€-23,912,750

PHM Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	17,574,931
Float Shares	12,739,364
Avg 10 Volume	44,448
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	29.37%
% Held by Institutions	8.67%

Stock Price Summary

Beta	-0.11
Fifty Two Week Low	€33.38
Fifty Two Week High	€105.80
Fifty Two Week Change	58.54%
Day 50 MA	€81.07
Day 200 MA	€78.55

Dividends and Splits

Forward Annual Dividend Rate	€3.20
Forward Annual Dividend Yield	3.82%
Trailing Annual Dividend Rate	€0.80
Trailing Annual Dividend Yield	0.95%
Payout Ratio	57.50%
Dividend Date
Ex Dividend Date	2025-06-25
Last Split Factor
Last Split Date	2020-07-22